Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -559.78% is 588% below its 5-year average of -81.39%, near the low end of its 5-year range (-750.74%–84.95%).
As of the fiscal period ended Tuesday, March 31, 2026. 160.89% below its 12-month average of -214.57%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
-559.78%
OPERATING MARGIN AVG TTM
-214.57%
OPERATING MARGIN AVG 3Y
-130.90%
OPERATING MARGIN AVG 5Y
-47.92%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-160.89%
CURRENT VS 3Y AVG
-327.64%
CURRENT VS 5Y AVG
-1068.19%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.48%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-3716.15%
vs the sector median at left
BioNTech SE
Market Cap
$22.91B
Operating Margin
-559.78%
TTM Avg
-214.57%
3Y Avg
-130.90%
5Y Avg
-47.92%
Market Cap
$21.98B
Operating Margin
45.34%
TTM Avg
47.77%
3Y Avg
49.26%
5Y Avg
45.01%
Market Cap
$24.00B
Operating Margin
20.64%
TTM Avg
20.32%
3Y Avg
22.80%
5Y Avg
22.92%
Market Cap
$21.75B
Operating Margin
-158.13%
TTM Avg
-140.72%
3Y Avg
-73.36%
5Y Avg
-52.24%
Market Cap
$24.23B
Operating Margin
31.57%
TTM Avg
14.26%
3Y Avg
15.92%
5Y Avg
12.23%
Market Cap
$24.59B
Operating Margin
28.22%
TTM Avg
28.07%
3Y Avg
28.30%
5Y Avg
28.33%
Market Cap
$25.35B
Operating Margin
11.23%
TTM Avg
9.61%
3Y Avg
9.32%
5Y Avg
13.00%
Market Cap
$20.45B
Operating Margin
-18.62%
TTM Avg
-9.28%
3Y Avg
-0.91%
5Y Avg
-0.93%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNTech SE (BNTX) | $22.91B | -559.78% | -214.57% | -130.90% | -47.92% |
| STERIS plc (STE)vs › | $22.26B | 18.56% | 17.21% | 17.04% | 16.18% |
| United Therapeutics Corporation (UTHR)vs › | $21.98B | 45.34% | 47.77% | 49.26% | 45.01% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.00B | 20.64% | 20.32% | 22.80% | 22.92% |
| Moderna, Inc. (MRNA)vs › | $21.75B | -158.13% | -140.72% | -73.36% | -52.24% |
| Incyte Corporation (INCY)vs › | $24.23B | 31.57% | 14.26% | 15.92% | 12.23% |
| Waters Corporation (WAT)vs › | $24.59B | 28.22% | 28.07% | 28.30% | 28.33% |
| Labcorp Holdings Inc. (LH)vs › | $25.35B | 11.23% | 9.61% | 9.32% | 13.00% |
| Viatris Inc. (VTRS)vs › | $20.45B | -18.62% | -9.28% | -0.91% | -0.93% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.72B | 14.14% | 14.08% | 14.06% | 16.54% |
Gross Margin
73.3%
Operating Margin
-559.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | -559.78% |
| 2025-12-31 | -25.66% |
| 2025-09-30 | -3.09% |
| 2025-06-30 | -192.14% |
| 2025-03-31 | -292.18% |
| 2024-12-31 | 12.49% |
| 2024-09-30 | 0.84% |
| 2024-06-30 | -750.74% |
| 2024-03-31 | -270.36% |
| 2023-12-31 | 35.58% |
| 2023-09-30 | 8.16% |
| 2023-06-30 | -335.90% |
| 2023-03-31 | 51.25% |
| 2022-12-31 | 76.97% |
| 2022-09-30 | 68.98% |
| 2022-06-30 | 69.13% |
| 2022-03-31 | 74.56% |
| 2021-12-31 | 84.95% |
| 2021-09-30 | 77.60% |
| 2021-06-30 | 79.09% |
| 2021-03-31 | 81.15% |
| 2020-12-31 | 70.69% |
| 2020-09-30 | -276.15% |
| 2020-06-30 | -194.00% |
| 2020-03-31 | -214.08% |
| 2019-12-31 | -189.16% |
| 2019-09-30 | -128.65% |
| 2019-06-30 | -185.64% |
| 2019-03-31 | -167.60% |
| 2018-12-31 | -3.76% |
| 2018-09-30 | -106.04% |
| 2018-06-30 | -68.74% |
| 2018-03-31 | -68.74% |
